Almenoff June Sherie
- SEC CIK
- 0001492647
Latest role at each company
- ATNM Actinium Pharmaceuticals, Inc.Directoras of Sep 4, 2026
- TENX TENAX THERAPEUTICS, INC.Directoras of Jan 13, 2026
- AVTX Avalo Therapeutics, Inc.Directoras of Jun 18, 2025
- BCLI BRAINSTORM CELL THERAPEUTICS INC.Directoras of Dec 17, 2021
Trades
Every Form 4 that lists Almenoff June Sherie as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| TENXTENAX THERAPEUTICS, INC. | Nov 20, 2025Amended | Nov 17 – Nov 18, 2025 | Almenoff June SherieDirector | PPurchaseCommon Stock | +1.99K | $7.5027 | +$14.95K | 1.99K | New position | SEC |
| AVTXAvalo Therapeutics, Inc. | Nov 14, 2024 | Nov 12 – Nov 13, 2024 | Almenoff June SherieDirector | PPurchaseCommon Stock | +1K | $12.75 | +$12.75K | 1K | New position | SEC |